Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques

Journal of Virology

Volumn 84, Issue 6, 2010, Pages 3043-3058

  Gordon, Shari N ^a   Weissman, Anna R ^a   Cecchinato, Valentina ^a   Fenizia, Claudio ^a   Ma, Zhong Min ^f   Lee, Tzong Hae ⁱ   Zaffiri, Lorenzo ^a   Andresen, Vibeke ^a   Parks, Robyn Washington ^a   Jones, Kathryn S ^b   Heraud, Jean Michel ^e   Ferrari, Maria Grazia ^c   Chung, Hye Kyung ^c   Venzon, David ^a   Mahieux, Renaud ^f   Murphy, Edward L ^h,i   Jacobson, Steven ^d   Miller, Christopher J ^g   Ruscetti, Francis W ^b   Franchini, Genoveffa ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f University Lyon i   (France)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN; VIRUS DNA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE EXACERBATION; FUNCTIONAL STATUS; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNE RESPONSE; INOCULATION; IRRADIATION; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MACACA; MALE; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; MACACA; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 77649089593     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01655-09     Document Type: Article

References (58)

1. Araujo, A., and W. W. Hall. 2004. Human T-lymphotropic virus type II and neurological disease. Ann. Neurol. 56:10-19.
2. Bartholomew, C., W. Blattner, and F. Cleghorn. 1987. Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad. Lancet 2:1469.
3. Bartman, M. T., Z. Kaidarova, D. Hirschkorn, R. A. Sacher, J. Fridey, G. Garratty, J. Gibble, J. W. Smith, B. Newman, A. E. Yeo, and E. L. Murphy. 2008. Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection. Blood 112:3995-4002.
4. Bassani, S., M. Lopez, C. Toro, V. Jimenez, J. M. Sempere, V. Soriano, and J. M. Benito. 2007. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients. Clin. Infect. Dis. 44:105-110.
5. Beilke, M. A., K. P. Theall, M. O'Brien, J. L. Clayton, S. M. Benjamin, E. L. Winsor, and P. J. Kissinger. 2004. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Clin. Infect. Dis. 39:256-263.
6. Beilke, M. A., V. L. Traina-Dorge, M. Sirois, A. Bhuiyan, E. L. Murphy, J. M. Walls, R. Fagan, E. L. Winsor, and P. J. Kissinger. 2007. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection. Clin. Infect. Dis. 44:1229-1234.
7. Betts, M. R., M. C. Nason, S. M. West, S. C. De Rosa, S. A. Migueles, J. Abraham, M. M. Lederman, J. M. Benito, P. A. Goepfert, M. Connors, M. Roederer, and R. A. Koup. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107:4781-4789.
8. Biglione, M., O. Vidan, R. Mahieux, M. de Colombo, M. de los Angeles de Basualdo, M. Bonnet, G. Pankow, M. A. De Efron, A. Zorrilla, F. Tekaia, E. Murphy, G. de The, and A. Gessain. 1999. Seroepidemiological and molecular studies of human T cell lymphotropic virus type II, subtype b, in isolated groups of Mataco and Toba Indians of northern Argentina. AIDS Res. Hum. Retroviruses 15:407-417.
9. Borrow, P., H. Lewicki, B. H. Hahn, G. M. Shaw, and M. B. A. Oldstone. 1994. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
10. Bovolenta, C., E. Pilotti, M. Mauri, B. Panzeri, M. Sassi, P. Dall'Aglio, U. Bertazzoni, G. Poli, and C. Casoli. 2002. Retroviral interference on STAT activation in individuals coinfected with human T cell leukemia virus type 2 and HIV-1. J. Immunol. 169:4443-4449.
11. Brown, D. A., F. B. Nelson, E. L. Reinherz, and D. J. Diamond. 1991. The human interferon-gamma gene contains an inducible promoter that can be transactivated by tax I and II. Eur. J. Immunol. 21:1879-1885.
12. Casoli, C., E. Pilotti, and U. Bertazzoni. 2007. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression. AIDS Rev. 9:140-149.
13. Casoli, C., E. Vicenzi, A. Cimarelli, G. Magnani, P. Ciancianaini, E. Cattaneo, P. Dall'Aglio, G. Poli, and U. Bertazzoni. 2000. HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha. Blood 95:2760-2769.
14. Cecchinato, V., E. Tryniszewska, Z. M. Ma, M. Vaccari, A. Boasso, W. P. Tsai, C. Petrovas, D. Fuchs, J. M. Heraud, D. Venzon, G. M. Shearer, R. A. Koup, I. Lowy, C. J. Miller, and G. Franchini. 2008. Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J. Immunol. 180:5439-5447.
15. Chung, H. K., T. Unangst, J. Treece, D. Weiss, and P. Markham. 2008. Development of real-time PCR assays for quantitation of simian betaretrovirus serotype-1, -2, -3, and -5 viral DNA in Asian monkeys. J. Virol. Methods 152:91-97.
16. Cocchi, F., A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811-1815.
17. Desrosiers, R. C. 2004. Prospects for an AIDS vaccine. Nat. Med. 10:221-223.
18. Dezzutti, C. S., D. R. Sasso, D. L. Rudolph, and R. B. Lal. 1998. Downregulation of interleukin-10 expression and production is associated with spontaneous proliferation by lymphocytes from human T lymphotropic virus type II-infected persons. J. Infect. Dis. 177:1489-1496.
19. Favre, D., S. Lederer, B. Kanwar, Z. M. Ma, S. Proll, Z. Kasakow, J. Mold, L. Swainson, J. D. Barbour, C. R. Baskin, R. Palermo, I. Pandrea, C. J. Miller, M. G. Katze, and J. M. McCune. 2009. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog. 5:e1000295.
20. Franchini, G. 2009. Choosing the right memory T cell for HIV. Nat. Med. 15:244-246.
21. Fultz, P. N., T. McGinn, I. C. Davis, J. W. Romano, and Y. Li. 1999. Coinfection of macaques with simian immunodeficiency virus and simian T cell leukemia virus type I: effects on virus burdens and disease progression. J. Infect. Dis. 179:600-611.
22. Gessain, A., F. Barin, J.-C. Vernant, O. Gout, L. Maurs, A. Calendar, and G. de The. 1985. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet ii:407-410.
23. Giacomo, M., E. G. Franco, C. Claudio, C. Carlo, D. A. Anna, D. Anna, and F. Franco. 1995. Human T-cell leukemia virus type II infection among high risk groups and its influence on HIV-1 disease progression. Eur. J. Epidemiol. 11:527-533.
24. Hall, W. W., R. Ishak, S. W. Zhu, P. Novoa, N. Eiraku, H. Takahashi, M. C. Ferreira, V. Azevedo, M. O. Ishak, O. C. Ferreira, C. Monken, and T. Kurata. 1996. Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13(Suppl 1):S204-S214.
25. Hansen, S. G., C. Vieville, N. Whizin, L. Coyne-Johnson, D. C. Siess, D. D. Drummond, A. W. Legasse, M. K. Axthelm, K. Oswald, C. M. Trubey, M. Piatak, Jr., J. D. Lifson, J. A. Nelson, M. A. Jarvis, and L. J. Picker. 2009. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 15:293-299.
26. Hershow, R. C., N. Galai, K. Fukuda, J. Graber, D. Vlahov, G. Rezza, R. S. Klein, J. Des, C. Vitek, R. Khabbaz, S. Freels, R. Zuckerman, P. Pezzotti, and J. E. Kaplan. 1996. An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J. Infect. Dis. 174:309-317.
27. Hishizawa, M., K. Imada, T. Kitawaki, M. Ueda, N. Kadowaki, and T. Uchiyama. 2004. Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals. Br. J. Haematol. 125:568-575.
28. Jones, K. S., C. Petrow-Sadowski, Y. K. Huang, D. C. Bertolette, and F. W. Ruscetti. 2008. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat. Med. 14:429-436.
29. Kalyanaraman, V. S., M. G. Sarngadharan, M. Robert-Guroff, I. Miyoshi, D. Golde, and R. C. Gallo. 1982. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 218:571-573.
30. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrew, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
31. Kwaan, N., T. H. Lee, D. M. Chafets, C. Nass, B. Newman, J. Smith, G. Garratty, and E. L. Murphy. 2006. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J. Infect. Dis. 194:1557-1564.
32. Lairmore, M. D., and G. Franchini. 2007. Human T-cell leukemia/lymphoma virus types 1 and 2, p. 2071-2106. In D. M. Knipe and P. M. Howley (ed.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, PA.
33. Lee, T. H., D. M. Chafets, M. P. Busch, and E. L. Murphy. 2004. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. J. Clin. Virol. 31:275-282.
34. Lefrere, J. J., A. M. Courouce, M. Mariotti, E. Wattel, O. Prou, F. Bouchardeau, and P. Lambin. 1990. Rapid progression to AIDS in dual HIV-1/HTLV-I infection. Lancet 336:509.
35. Lehner, T., Y. Wang, M. Cranage, L. Tao, E. Mitchell, C. Bravery, C. Doyle, K. Pratt, G. Hall, M. Dennis, L. Villinger, and L. Bergmeier. 2000. Upregulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates. Immunology 99:569-577.
36. Lewis, M. J., V. W. Gautier, X. P. Wang, M. H. Kaplan, and W. W. Hall. 2000. Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals. J. Immunol. 165:4127-4132.
37. Loughran, T. P., Jr., T. Coyle, M. P. Sherman, G. Starkebaum, G. D. Ehrlich, F. W. Ruscetti, and B. J. Poiesz. 1992. Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood 80:1116-1119.
38. Loughran, T. P., Jr., M. P. Sherman, F. W. Ruscetti, S. Frey, T. Coyle, R. A. Montagna, B. Jones, G. Starkebaum, and B. J. Poiesz. 1994. Prototypical HTLV-I/II infection is rare in LGL leukemia. Leuk. Res. 18:423-429.
39. Martin, M. P., R. J. Biggar, G. Hamlin-Green, S. Staal, and D. Mann. 1993. Large granular lymphocytosis in a patient infected with HTLV-II. AIDS Res. Hum. Retroviruses 9:715-719.
40. Meertens, L., S. Chevalier, R. Weil, A. Gessain, and R. Mahieux. 2004. A 10-amino acid domain within human T-cell leukemia virus type 1 and type 2 tax protein sequences is responsible for their divergent subcellular distribution. J. Biol. Chem. 279:43307-43320.
41. Migone, T. S., J. X. Lin, A. Cereseto, J. C. Mulloy, J. J. O'Shea, G. Franchini, and W. J. Leonard. 1995. Constitutively activated JAK-STAT pathway in T-cells transformed with HTLV-I. Science 269:79-81.
42. Mulloy, J. C., T.-S. Migone, T. M. Ross, N. Ton, P. L. Green, W. J. Leonard, and G. Franchini. 1998. Human and simian T-cell leukemia viruses type 2 (HTLV-2 and STLV-2pan-p) transform T cells independently of Jak/STAT activation. J. Virol. 72:4408-4412.
43. Murphy, E. L., T. H. Lee, D. Chafets, C. C. Nass, B. Wang, K. Loughlin, and D. Smith. 2004. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion. J. Infect. Dis. 190:504-510.
44. Orland, J. R., J. Engstrom, J. Fridey, R. A. Sacher, J. W. Smith, C. Nass, G. Garratty, B. Newman, D. Smith, B. Wang, K. Loughlin, and E. L. Murphy. 2003. Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology 61:1588-1594.
45. Osame, M., M. Matsumoto, K. Usuku, S. Izumo, N. Ijichi, H. Amitani, M. Tara, and A. Igata. 1987. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann. Neurol. 21:117-122.
46. Pawson, R., T. F. Schulz, E. Matutes, and D. Catovsky. 1997. The human T-cell lymphotropic viruses types I/II are not involved in T prolymphocytic leukemia and large granular lymphocytic leukemia. Leukemia 11:1305-1311.
47. Pilotti, E., L. Elviri, E. Vicenzi, U. Bertazzoni, M. C. Re, S. Allibardi, G. Poli, and C. Casoli. 2007. Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replication. Blood 109:1850-1856.
48. Pitcher, C. J., S. I. Hagen, J. M. Walker, R. Lum, B. L. Mitchell, V. C. Maino, M. K. Axthelm, and L. J. Picker. 2002. Development and homeostasis of T cell memory in rhesus macaque. J. Immunol. 168:29-43.
49. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 77:7415-7419.
50. Poiesz, B. J., F. W. Ruscetti, M. S. Reitz, V. S. Kalyanaraman, and R. C. Gallo. 1981. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukaemia. Nature 294:268-271.
51. Romano, J. W., K. G. Williams, R. N. Shurtliff, C. Ginocchio, and M. Kaplan. 1997. NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics. Immunol. Invest. 26:15-28.
52. Scarlatti, G., E. Tresoldi, A. Bjorndal, R. Fredriksson, C. Colognesi, H. K. Deng, M. S. Malnati, A. Plebani, A. G. Siccardi, D. R. Littman, E. M. Fenyo, and P. Lusso. 1997. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3:1259-1265.
53. Shimotohno, K., Y. Takahashi, N. Shimizu, T. Gojobori, D. W. Golde, I. S. Chen, M. Miwa, and T. Sugimura. 1985. Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc. Natl. Acad. Sci. U. S. A. 82:3101-3105.
54. Switzer, W. M., F. L. Black, D. Pieniazek, R. J. Biggar, R. B. Lal, and W. Heneine. 1996. Endemicity and phylogeny of the human T cell lymphotropic virus type II subtype A from the Kayapo Indians of Brazil: evidence for limited regional dissemination. AIDS Res. Hum. Retroviruses 12:635-640.
55. Traina-Dorge, V. L., L. N. Martin, R. Lorino, E. L. Winsor, and M. A. Beilke. 2007. Human T cell leukemia virus type 1 up-regulation after simian immunodeficiency virus-1 coinfection in the nonhuman primate. J. Infect. Dis. 195:562-571.
56. Turci, M., E. Pilotti, P. Ronzi, G. Magnani, A. Boschini, S. G. Parisi, D. Zipeto, A. Lisa, C. Casoli, and U. Bertazzoni. 2006. Coinfection with HIV-1 and human T-cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS. J. Acquir. Immune Defic. Syndr. 41:100-106.
57. Vrielink, H., and H. W. Reesink. 2004. HTLV-I/II prevalence in different geographic locations. Transfus. Med. Rev. 18:46-57.
58. Willy, R. J., C. M. Salas, G. E. Macalino, and J. D. Rich. 1999. Long-term non-progression of HIV-1 in a patient coinfected with HTLV-II. Diagn. Microbiol. Infect. Dis. 35:269-270